Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson settles U.S. bribery charges

By Parija Kavilanz, senior writer


NEW YORK (CNNMoney) -- The Securities and Exchange Commission on Friday charged Johnson & Johnson with bribing doctors in several countries to prescribe its drugs and medical devices.

The company has agreed to pay $70 million to settle the charges, without admitting or denying the allegations.

This is the latest setback amid mounting problems for the pharmaceutical giant. Johnson & Johnson's (JNJ, Fortune 500), drugmaking arm McNeil Consumer Healthcare is already under federal supervision due to numerous recalls of its Tylenol and other non-prescription medicines over the past year.

J&J also faces numerous lawsuits files by patients who received defective hip replacement devices manufactured by its DePuy Orthopaedics unit.

The SEC alleges that since at least 1998, J&J subsidiaries paid bribes to doctors in Greece to select its surgical implants, to doctors and hospital administrators in Poland to win contracts to doctors in Romania to prescribe J&J drugs.

The agency said J&J subsidiaries also paid kickbacks to Iraq to obtain 19 contracts under the United Nations Oil for Food Program.

J&J subsidiaries, employees and agents used slush funds, sham civil contracts with doctors, and off-shore companies in the Isle of Man to carry out the bribery. These acts violate the Foreign Corrupt Practices Act, the agency said.

"The message in this is plain. Any competitive advantage gained through corruption is a mirage," Robert Khuzami, Director of the SEC's Division of Enforcement, said in a statement.

"J&J chose profit margins over compliance with the law by acquiring a private company for the purpose of paying bribes, and using sham contracts, off-shore companies, and slush funds to cover its tracks," he said.

J&J said it hopes to reach a settlement of a related investigation by the U.K. Serious Fraud Office in the coming days.

J&J CEO William Weldon said the company reported the improper payments to the government more than four years ago and has taken full responsibility.

"We are deeply disappointed by the unacceptable conduct that led to these violations," he said, adding that the company is committed to making sure this doesn't happen again." To top of page

Index Last Change % Change
Dow 17,400.75 -610.32 -3.39%
Nasdaq 4,707.98 -202.06 -4.12%
S&P 500 2,037.41 -75.91 -3.59%
Treasuries 1.58 -0.16 -9.20%
Data as of 7:20pm ET
Company Price Change % Change
Bank of America Corp... 13.00 -1.04 -7.41%
Microsoft Corp 49.83 -2.08 -4.01%
Ford Motor Co 12.52 -0.88 -6.57%
General Electric Co 29.82 -1.37 -4.39%
Micron Technology In... 13.21 -0.84 -5.98%
Data as of Jun 24
Sponsors

Sections

Barnes and Noble announced plans to start selling alcohol in some of its stores. And shares of the bookstore chain rallied on the news while the rest of the market was down on Brexit fears. More

Both candidates would increase the country's debt, but Trump would do so "massively," according to a new analysis. More

Startup Spark examined the effects that political candidates had on the human brain and nervous system using a device called BrainWave. Here's what it found. More